Photo courtesy of Aevice Health

照片由Aevice Health提供

Aevice Health obtains $1M investment for Japan, US expansion

Aevice Health为日本和美国扩张获得100万美元投资

Singapore-based respiratory health IT maker Aevice Health has received a $1 million investment from A&D Company for its expansion in the United States and Japan.

总部位于新加坡的呼吸健康IT制造商Aevice health从a＆D公司获得了100万美元的投资，用于其在美国和日本的扩张。

Based on their agreement, Aevice can leverage the sales network of its investor, which manufactures precision equipment and product inspection equipment for healthcare and laboratories worldwide. In turn, Japan-headquartered A&D will be acquiring shares in Aevice, have the right to invest in its future funding rounds, and harness its technology to develop new products and services. .

根据他们的协议，Aevice可以利用其投资者的销售网络，该投资者为全球医疗保健和实验室制造精密设备和产品检测设备。反过来，总部位于日本的A＆D将收购Aevice的股份，有权投资其未来的融资回合，并利用其技术开发新产品和服务。。

Aevice offers a patient management platform for patients with chronic respiratory ailments. Featuring a smart wearable stethoscope, AeviceMD has been certified by regulatory bodies in Singapore and the United States.

Aevice为慢性呼吸系统疾病患者提供患者管理平台。AeviceMD拥有智能可穿戴听诊器，已获得新加坡和美国监管机构的认证。

Lunit completes Volpara acquisition

Lunit完成Volpara采集

New Zealand-headquartered Volpara Health Technologies has been fully acquired by South Korean medical AI giant Lunit.

总部位于新西兰的Volpara Health Technologies已被韩国医疗AI巨头Lunit完全收购。

Lunit is now integrating Volpara's AI breast health platforms, including the Scorecard breast density assessment tool, into its line of AI solutions for breast cancer detection.

Lunit目前正在将Volpara的AI乳腺健康平台（包括记分卡乳腺密度评估工具）整合到其用于乳腺癌检测的AI解决方案中。

The acquisition will support Lunit's expansion to the United States where Volpara is used in over 2,000 medical sites. The US healthcare AI market is projected to grow to over $50 billion by 2030. Additionally, there is an anticipated increase in demand for breast cancer screening among American women as screening has been recommended to women below age 50. .

此次收购将支持Lunit在美国的扩张，Volpara在2000多个医疗场所使用。预计到2030年，美国医疗保健人工智能市场将增长至500多亿美元。此外，由于建议对50岁以下的女性进行筛查，预计美国女性对乳腺癌筛查的需求会增加。

Moving forward, both companies are keen to collaborate in developing autonomous AI models, as well as screening solutions for other cancer types. Lunit also intends to introduce Volpara's solutions in markets beyond the US.

展望未来，两家公司都热衷于合作开发自主AI模型，以及筛选其他癌症类型的解决方案。Lunit还打算将Volpara的解决方案引入美国以外的市场。

New healthcare networking platform goes live

新医疗网络平台上线

A new networking platform that connects healthcare startups, investors, distributors, and service providers has been recently launched.

最近推出了一个新的网络平台，将医疗保健初创公司、投资者、分销商和服务提供商联系起来。

VentureBlick, an incubator firm from Singapore, said its platform, Discovery, is the first of its kind that '[brings] together key stakeholders in healthcare innovation under one virtual roof.'

新加坡孵化器公司VentureBlick表示，其平台Discovery是第一个将医疗创新的关键利益相关者聚集在一个虚拟屋顶下的同类平台

The free online platform features exclusive access to a curated list of advisers (clinicians or industry experts) who are part of the global VentureBlick Advisory Network. Upcoming features, including Open Innovation Search, 1-to-1 expert call on-demand, smart matching, and open Q&A forum, are expected in the coming months. .

该免费在线平台的特点是独家访问全球VentureBlick咨询网络的顾问（临床医生或行业专家）精选名单。预计未来几个月将推出开放式创新搜索、1对1专家点播、智能匹配和开放式问答论坛等新功能。。

Since its soft launch, it has onboarded nearly 3,000 individuals from 50 countries.

自软启动以来，它已经为来自50个国家的近3000人提供了服务。

Tags: Aevice Health, A&D, Singapore, Lunit, Volpara Health, VentureBlick

标签：Aevice Health，A＆D，新加坡，Lunit，Volpara Health，VentureBlick

More regional news

更多地区新闻

Samsung Medison buying French ultrasound AI startup for $92MBy Adam AngMay 14, 2024

三星麦迪逊以9200万美元收购法国超声波人工智能初创公司AdamAng2024年5月14日

South Korea OKs DTx for vision loss, respiratory rehabBy Adam AngApril 30, 2024

韩国OKs DTx治疗视力丧失，呼吸康复Adam Ang2024年4月30日

Ring-type sensor in Singapore measures skin feelBy Adam AngApril 29, 2024

2024年4月29日，新加坡的环形传感器测量皮肤的触感